Clinical trial
Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
NCT00817375 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
- Lead sponsor
- Samsung Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 28, 2003
- Completion date
- December 31, 2018
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adverse reaction to drug, depression